Pharmaceutical compositions of 3-(6- (1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereof

Details for Australian Patent Application No. 2011237601 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Verwijs, Marinus Jacobus; Alargova, Rossitza Gueorguieva; Kaushik, Ritu Rohit; Kadiyala, Irina Nikolaevna; Young, Christopher Ryan

Agent Spruson & Ferguson

Pub. Number AU-A-2011237601

PCT Pub. Number WO2011/127241

Priority 61/366,562 22.07.10 US; 61/321,729 07.04.10 US; 61/321,748 07.04.10 US

Filing date 7 April 2011

Wipo publication date 13 October 2011

International Classifications

A61K 9/20 Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

Event Publications

1 November 2012 PCT application entered the National Phase

  PCT publication WO2011/127241 Priority application(s): WO2011/127241

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011237612-Miniature ingestible device

2011237600-Methods of using diacerein as an adjunctive therapy for diabetes